The double-blind multicenter phase 3 trials STEP 1, 3, 4, 5 were conducted in adults (mean age 46.247.3 years), mostly females, with obesity or overweight with 1 weight-related complication (mean BMI 37.838.4 kg/m 2 ) and aimed to demonstrate the superiority of semaglutide 2.4 mg over placebo in BW lowering at 68 or 104 24 weeks as an adjunct to diet and physical activity 23
If cost is a primary concern, exploring Rybelsus as an oral Semaglutide option removes the need for injections and can be a practical alternative for patients who prefer a pill format
rash) For less urgent concerns, contact your GP or call NHS 111
Despite the setback, reports suggest Janhvi is recovering well and might even be discharged by Friday
Whether rescuing GABA-related gene defects through genetic methods can improve behavior is worthy of further exploration (102, 109)